Skip to main content
. 2010 Jan 12;115(14):2882–2890. doi: 10.1182/blood-2009-07-235119

Figure 3.

Figure 3

Genomic alterations per MPN patient in chronic versus blast phase. (A) Mean of SNP-array alterations per patient in MPN versus MPN-blast phase with (i) unmatched samples and (ii) matched samples (± SD); **P < .001. (B) Mean of SNP-array aberrations compared with cytogenetic alterations per patient in chronic versus blast phase with (i) unmatched samples and (ii) matched samples (± SD).